Influence of Sustained Low-Efficiency Dialysis Treatment on Isavuconazole Plasma Levels in Critically Ill Patients.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
11 2019
Historique:
received: 05 06 2019
accepted: 13 08 2019
pubmed: 21 8 2019
medline: 7 8 2020
entrez: 21 8 2019
Statut: epublish

Résumé

Isavuconazole plasma concentrations were measured before and after sustained low-efficiency dialysis (SLED) treatment in 22 critically ill adult patients with probable invasive aspergillosis and underlying hematological malignancies. Isavuconazole levels were significantly lower after SLED treatment (5.73 versus 3.36 μg/ml;

Identifiants

pubmed: 31427296
pii: AAC.01162-19
doi: 10.1128/AAC.01162-19
pmc: PMC6811396
pii:
doi:

Substances chimiques

Antifungal Agents 0
Nitriles 0
Pyridines 0
Triazoles 0
isavuconazole 60UTO373KE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Clin Microbiol Infect. 2016 Jun;22(6):571.e1-4
pubmed: 26851656
Antimicrob Agents Chemother. 2018 Jun 26;62(7):
pubmed: 29735569
Haematologica. 2017 Mar;102(3):433-444
pubmed: 28011902
Kidney Int. 2002 Sep;62(3):986-96
pubmed: 12164882
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38
pubmed: 29544767
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60
pubmed: 27365388
N Engl J Med. 2002 Jan 31;346(5):305-10
pubmed: 11821506
J Mycol Med. 2018 Mar;28(1):8-14
pubmed: 29534853
J Mycol Med. 2018 Mar;28(1):15-22
pubmed: 29551442
J Antimicrob Chemother. 2016 Jul;71(7):1885-91
pubmed: 27084921
Crit Care. 2014 Oct 30;18(5):618
pubmed: 25673133
Clin Infect Dis. 2007 Jul 15;45(2):205-16
pubmed: 17578780
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003234
pubmed: 16034894
Artif Organs. 2018 Feb;42(2):200-207
pubmed: 29027687
Lancet. 2016 Feb 20;387(10020):760-9
pubmed: 26684607
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
pubmed: 18462102

Auteurs

Tobias Lahmer (T)

Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität Munich, Munich, Germany tobiaslahmer@me.com.

Gonzalo Batres Baires (G)

Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität Munich, Munich, Germany.

Markus Heilmaier (M)

Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität Munich, Munich, Germany.

Roland M Schmid (RM)

Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität Munich, Munich, Germany.

Fritz Sörgel (F)

Institute for Biomedical and Pharmaceutical Research (IBMP), Nürnberg-Heroldsberg, Germany.
Institute of Pharmacology, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.

Martina Kinzig (M)

Institute for Biomedical and Pharmaceutical Research (IBMP), Nürnberg-Heroldsberg, Germany.

Wolfgang Huber (W)

Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität Munich, Munich, Germany.

Ulrich Mayr (U)

Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität Munich, Munich, Germany.

Sebastian Rasch (S)

Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der Technischen Universität Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH